| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/09/2009 | WO2009043584A2 Use of polymorphisms in the tmem132d gene in the prediction and treatment of anxiety disorders |
| 04/09/2009 | WO2009043178A1 Biomarkers for autism spectrum disorders |
| 04/09/2009 | WO2009043173A1 Cc2d2a gene mutations associated with joubert syndrome and diagnostic methods for identifying the same |
| 04/09/2009 | WO2009043163A1 Bacterial degradation of paralytic shellfish toxins |
| 04/09/2009 | WO2009043159A1 Neural tumor stem cells and methods of use thereof |
| 04/09/2009 | WO2009043132A1 Genetic polymorphism of n-acetyltransferase 2 (nat2) and use in medicine. |
| 04/09/2009 | WO2009043112A1 Nucleic acid amplification |
| 04/09/2009 | WO2009043096A1 Improved method for mutagenesis |
| 04/09/2009 | WO2009023819A3 Toll like receptor modulators |
| 04/09/2009 | WO2009021683A3 Predictive marker for egfr inhibitor treatment |
| 04/09/2009 | WO2009021681A3 Egfr inhibitor treatment marker |
| 04/09/2009 | WO2009021240A9 Sensing and identifying biological sampels on microfluidic devices |
| 04/09/2009 | WO2009016231A3 Compositions and methods for detecting histamine related disorders |
| 04/09/2009 | WO2009015233A3 Gefitinib sensitivity-related gene expression and products and methods related thereto |
| 04/09/2009 | WO2009014766A3 Non-invasive recovery of rna and analysis of gene expression in skin |
| 04/09/2009 | WO2009009769A3 Diagnosis of fetal abnormalities using nucleated red blood cells |
| 04/09/2009 | WO2009009743A3 Sequence optimization for expression of a foreign gene |
| 04/09/2009 | WO2009009613A3 Novel ion channel-forming peptides |
| 04/09/2009 | WO2009009127A3 Method and system for transferring and/or concentrating a sample |
| 04/09/2009 | WO2009008720A3 Small rna molecules, precursors thereof, means and methods for detecting them, and uses thereof in typing samples |
| 04/09/2009 | WO2009007719A3 Detection of micro-organisms based on their nad-dependent dna ligase activity |
| 04/09/2009 | WO2009003905A3 Prognostic method for the determination of the suitability of biopharmaceutical treatment |
| 04/09/2009 | WO2009000912A3 Fusion gene microarray |
| 04/09/2009 | WO2008152124A3 Biosensor |
| 04/09/2009 | WO2008150461A4 High throughput screening of genetically modified photosynthetic organisms |
| 04/09/2009 | WO2008147869A3 Markers and methods for assessing and treating crohn's disease and related disorders |
| 04/09/2009 | WO2008133749A9 Antimicrobial agents from microbial genomes |
| 04/09/2009 | WO2008132176A3 Method for evaluating the response of an individual to tnf blocking therapy |
| 04/09/2009 | WO2008083327A3 Enrichment through heteroduplexed molecules |
| 04/09/2009 | WO2008079298A3 Cells for detection and production of influenza and parainfluenza viruses |
| 04/09/2009 | WO2008071385A8 Use of acetals for the isolation of nucleic acids |
| 04/09/2009 | WO2008070666A3 Compositions and methods to treat cancer with cpg rich dna and cupredoxins |
| 04/09/2009 | WO2008070222A3 A method of surface plasmon resonance (spr) technology to detect genomic disorders for prenatal diagnosis |
| 04/09/2009 | WO2008063760A3 Methods for treating cancer targeting transglutaminase |
| 04/09/2009 | WO2008054834A3 Binary deoxyribozyme probes for nucleic acid analysis |
| 04/09/2009 | WO2008030281A3 Optical resonances in droplets in a microchannel |
| 04/09/2009 | WO2008028031A3 Markers and methods for assessing and treating ulcerative colitis and related disorders using a 43 gene panel |
| 04/09/2009 | WO2007134014A3 Compounds and methods for modulating expression of gcgr |
| 04/09/2009 | WO2007133871A3 Two-phase optical assay with unitized container and double or single sensor systems |
| 04/09/2009 | WO2007121459A3 Detection of steroid receptors on circulating carcinoma cells and treatment |
| 04/09/2009 | WO2007106903A3 Polyunsaturated fatty acid production in heterologous organisms using pufa polyketide synthase systems |
| 04/09/2009 | WO2007103823A3 Genetic markers for predicting disease and treatment outcome |
| 04/09/2009 | WO2007100711A3 Methods and compositions for detecting polynucleotides |
| 04/09/2009 | WO2007086070A3 Method for diagnosing of skin diseases caused by a mutation in the znf750 gene |
| 04/09/2009 | WO2007081874A3 System and method for clasifying cells and the pharmaceutical treatment of such cells using raman spectroscopy |
| 04/09/2009 | WO2007078841A3 Diagnosis of sepsis |
| 04/09/2009 | WO2007075655A3 Compositions and methods for altering rnai |
| 04/09/2009 | WO2007049276A3 Compositions for- detecting of influenza viruses and kits and methods using same |
| 04/09/2009 | WO2007008472A3 Photoinduced signal amplification through externally sensitized photofragmentation in masked photosensitizers |
| 04/09/2009 | WO2007002204A3 Pyrosequencing methods and related compostions |
| 04/09/2009 | WO2006124408A3 System and method for automated selection of t-cell epitopes |
| 04/09/2009 | WO2006121510A3 Point-of-care fluidic systems and uses thereof |
| 04/09/2009 | WO2006105110A3 Assay device and methods |
| 04/09/2009 | WO2006101520A3 Fluorescent proteins and related methods and compounds |
| 04/09/2009 | WO2006099248A3 Drug delivery from electroactive molecularly imprinted polymer |
| 04/09/2009 | WO2006098952A3 Corn event 3272 and methods of detection thereof |
| 04/09/2009 | WO2006079101A3 Associations using genotypes and phenotypes |
| 04/09/2009 | WO2006079049A3 Methods and compositions for increased dynamic range detection of nucleic acid molecules |
| 04/09/2009 | WO2006076153A3 Inherited mitochondrial dna mutations in cancer |
| 04/09/2009 | WO2006076047A3 Electrocatalytic nucleic acid hybridization detection |
| 04/09/2009 | WO2006076024A3 A method for targeting synapse with acetylcholinesterase |
| 04/09/2009 | WO2006063135A3 Tubulin isotype screnning in cancer therapy using hemiasterlin analogs |
| 04/09/2009 | WO2006063031A3 Allelic variants of human factor viii |
| 04/09/2009 | WO2006055665A3 Roles for dual endothelin-1/angiotensin ii receptor (dear) in hypertension and angiogenesis |
| 04/09/2009 | WO2006052871A3 Docosahexaenoic acid producing strains of yarrowia lipolytica |
| 04/09/2009 | WO2006052735A3 Fibulin-3 and uses thereof |
| 04/09/2009 | WO2006052409A3 Peptide and small molecule agonists of epha and their uses |
| 04/09/2009 | WO2006046994A3 Klf6 alternative splice forms and a germline klf6 dna polymorphism associated with increased cancer risk |
| 04/09/2009 | WO2006039630A3 Materials and methods for identifying compounds that modulate the cell cycle |
| 04/09/2009 | WO2006033768A3 Hcv multiple epitope fusion antigens with modified proteolytic cleavage sites and uses thereof |
| 04/09/2009 | WO2006031524A3 Early detection of hemangiosarcoma and angiosarcoma |
| 04/09/2009 | WO2006019984A3 Compositions, methods and kits for the diagnosis and treatment of sudden infant death syndrome |
| 04/09/2009 | WO2006017150A3 Identification of markers in lung and breast cancer |
| 04/09/2009 | WO2006007400A9 Methods of diagnosing and treating obesity, diabetes and insulin resistance |
| 04/09/2009 | WO2006002053A3 Helicases |
| 04/09/2009 | WO2005123954A3 Methods for target molecule detection using siderophores and related compositions |
| 04/09/2009 | WO2005118876A3 Egfr mutations |
| 04/09/2009 | WO2005115115A3 Method of measuring cancer susceptibility |
| 04/09/2009 | WO2005113833A3 Polymorphism in tryptophan hydroxylase-2 controls brain serotonin synthesis |
| 04/09/2009 | WO2005113810A9 One component and two component dna pol iii replicases and uses thereof |
| 04/09/2009 | WO2005100613A3 Ultraviolet lidar for detection of biological warfare agents |
| 04/09/2009 | WO2005094441A3 Split enzyme linked immunosorbent and nucleic acid assays |
| 04/09/2009 | WO2005086775A3 Lumen-exposed molecules and methods for targeted delivery |
| 04/09/2009 | WO2005084277A3 Method of isolating nucleic acid targets |
| 04/09/2009 | WO2005079548A3 Narcotic analgesic tracking system |
| 04/09/2009 | WO2005047305A3 Cellular membrane protein assay |
| 04/09/2009 | WO2005044990A3 Use of differentially expressed nucleic acid sequences as biomarkers for cancer |
| 04/09/2009 | WO2005032496A3 Hydrolases, nucleic acids encoding them and mehods for making and using them |
| 04/09/2009 | WO2005030978A3 Self-assembled circuits and circuit patterns |
| 04/09/2009 | WO2005027715A3 CRYSTALS AND STRUCTURES OF SARS-CoV MAIN PROTEASE |
| 04/09/2009 | WO2005024603A3 Methods for detecting, diagnosing and treating human renal cell carcinoma |
| 04/09/2009 | WO2005021712A3 Modified molecular beacons |
| 04/09/2009 | WO2005010486A3 Biomarker panel for colorectal cancer |
| 04/09/2009 | WO2005010199A3 Invasive cleavage reaction with electrochemical readout |
| 04/09/2009 | WO2005007078A3 Method of inhibiting human metapneumovirus and human coronavirus in the prevention and treatment of severe acute respiratory syndrome (sars) |
| 04/09/2009 | WO2004113361A3 Novel prokineticin receptor isoforms and methods of use |
| 04/09/2009 | WO2004092200A3 Peptide substrate libraries |
| 04/09/2009 | WO2004079334A3 Biomarker detection based on aspects of ion mobility |
| 04/09/2009 | WO2004077021A3 Standardized evaluation of therapeutic efficacy based on cellular biomarkers |
| 04/09/2009 | US20090094717 Nucleotide sequences and corresponding polypeptides conferring modulated plant characteristics |